Skip to main content

A Spanish biotech combats schizophrenia thanks to micropatronage

Images

Participants

Image
Alumni - Research Associate
Tel.+34 93 40 37127
Image
Emeritus Professor
Tel.+34 93 40 37125

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Elconfidencial.com has published an article about the initiative conducted by Iproteos, a spin-off founded by Teresa Tarragó and Ernest Giralt, to finance its research on a drug against schizophrenia through equity crowdfunding. Tarragó explains the results of this experience, the phases that will be reached, and her future projects.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).